Summary: Acadia won approval for its only commercialized drug Nuplazid in 2017 and has tried
Summary: Affimed has generated an impressive pipeline of innate cell engagers programs created using their
Summary: Abercrombie & Fitch released its Q1 results last month, managing to grow sales year-over-year
Summary: 360 DigiTech’s core competencies of asset-light model and technology focus offer a bright future.
Summary: 360 DigiTech, Inc. is a credit-tech platform that financial institutions use to provide better
Summary: The higher valuation multiples for Ambarella relative to its peers are unjustified, taking into
Summary: Mullen has a plethora of positive catalysts coming up in June. The official start
Summary: Capital One saw a great year in 2021 due to the lowering of the
Summary: Ambarella operates in buzzword areas, but its growth has slowed. The company is generating
Summary: Ambarella cut guidance for current quarter revenues by a sizable amount due to supply